FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

Title
FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 5, Pages 950-954
Publisher
American Association for Cancer Research (AACR)
Online
2015-01-20
DOI
10.1158/1078-0432.ccr-14-1678

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now